Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

72 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Socioeconomic Inequalities and Severity of Plaque Psoriasis at a First Consultation in Dermatology Centers.
Mahé E, Beauchet A, Reguiai Z, Maccari F, Ruer-Mulard M, Chaby G, Le Guyadec T, Estève E, Goujon-Henry C, Parier J, Barthelemy H, Bégon E, Steiner HG, Bénéton N, Boyé T, Mery-Bossard L, Schmutz JL, Bravard P; Michèle-Léa Sigal and the GEM RESOPSO. Mahé E, et al. Among authors: boye t. Acta Derm Venereol. 2017 May 8;97(5):632-638. doi: 10.2340/00015555-2625. Acta Derm Venereol. 2017. PMID: 28127620 Free article.
Factors associated with successful switching between biologic therapies for the treatment of psoriasis in daily dermatological real-life practice: The Resoswitch study.
Dabouz F, Khemis A, Barbe C, Lahfa M, Maccari F, Chaby G, Beneton N, Boye T, Esteve E, Mahé E, Begon E, Pauwels C, Bernard P, Taieb C, Reguiai Z; Resopso network. Dabouz F, et al. Among authors: boye t. Dermatol Ther. 2019 Mar;32(2):e12789. doi: 10.1111/dth.12789. Epub 2019 Jan 17. Dermatol Ther. 2019. PMID: 30488520 No abstract available.
Evaluation of risk factors for body weight increment in psoriatic patients on infliximab: a multicentre, cross-sectional study.
Mahé E, Reguiai Z, Barthelemy H, Quiles-Tsimaratos N, Chaby G, Girard C, Estève E, Maccari F, Descamps V, Schmutz JL, Begon E, Bravard P, Maillard H, Boyé T, Beauchet A, Sigal ML; GEM Resopso. Mahé E, et al. Among authors: boye t. J Eur Acad Dermatol Venereol. 2014 Feb;28(2):151-9. doi: 10.1111/jdv.12066. Epub 2012 Dec 28. J Eur Acad Dermatol Venereol. 2014. PMID: 23279264
Methotrexate efficacy and tolerance in plaque psoriasis. A prospective real-life multicentre study in France.
Tournier A, Khemis A, Maccari F, Reguiai Z, Bégon E, Fougerousse AC, Amy de la Breteque M, Beneton N, Parier J, Boyé T, Avenel-Audran M, Girard C, Pallure V, Perrot JL, Bastien M, Mahé E, Beauchet A; GEM Resopso. Tournier A, et al. Among authors: boye t. Ann Dermatol Venereol. 2019 Feb;146(2):106-114. doi: 10.1016/j.annder.2018.11.011. Epub 2019 Jan 28. Ann Dermatol Venereol. 2019. PMID: 30704943
Combining Omalizumab with Another Biotherapy.
Fougerousse AC, Becherel PA, Pallure V, Boyé T, Reguiai Z, Gabison G, Barthelemy H, Badaoui A, Mahé E, Livideanu CB; GEM ResoPso. Fougerousse AC, et al. Among authors: boye t. Acta Derm Venereol. 2019 Apr 1;99(4):448-449. doi: 10.2340/00015555-3140. Acta Derm Venereol. 2019. PMID: 30723874 Free article. No abstract available.
Factors that may influence the choice for initiating apremilast or methotrexate treatment for psoriasis in real-world clinical setting.
Fougerousse AC, Maccari F, Beauchet A, Parier J, Boulard C, Becherel PA, Quiles-Tsimaratos N, Le Guyadec T, Thomas-Beaulieu D, Halioua B, Begon E, Bastien M, Perrot JL, Pallure V, Bilan P, Steff M, Pfister P, Vermersch-Langlin A, Boyé T, Mery-Bossard L, Maillard H, Kemula M, Girard C, Poiraud C, Monfort JB, Kupfer-Bessaguet I, Perrussel M, Lons-Danic D, Sultan N, Lorier E, Zeitoun M, Wagner L, Gabison G, Mahé E; GEM Resopso. Fougerousse AC, et al. Among authors: boye t. J Eur Acad Dermatol Venereol. 2019 Dec;33(12):e476-e478. doi: 10.1111/jdv.15804. Epub 2019 Jul 30. J Eur Acad Dermatol Venereol. 2019. PMID: 31310364 No abstract available.
New-onset vitiligo and progression of pre-existing vitiligo during treatment with biological agents in chronic inflammatory diseases.
Méry-Bossard L, Bagny K, Chaby G, Khemis A, Maccari F, Marotte H, Perrot JL, Reguiai Z, Sigal ML, Avenel-Audran M, Boyé T, Grasland A, Gillard J, Jullien D, Toussirot E. Méry-Bossard L, et al. Among authors: boye t. J Eur Acad Dermatol Venereol. 2017 Jan;31(1):181-186. doi: 10.1111/jdv.13759. Epub 2016 Jun 13. J Eur Acad Dermatol Venereol. 2017. PMID: 27291924
[Misdiagnosis of hidradenitis suppurativa continues to be a major issue. The R-ENS Verneuil study].
Loget J, Saint-Martin C, Guillem P, Kanagaratnam L, Becherel PA, Nassif A, Fougerousse AC, Siham M, Girard C, Barthelemy H, Chaby G, Gabison G, Perrot JL, Pallure V, Beneton N, Boye T, Jacobzone C, Begon E, Bernard P, Reguiai Z; sous l’égide de « ResoVerneil ». Loget J, et al. Among authors: boye t. Ann Dermatol Venereol. 2018 May;145(5):331-338. doi: 10.1016/j.annder.2018.01.043. Epub 2018 Apr 26. Ann Dermatol Venereol. 2018. PMID: 29704958 French.
Management of pain associated with debridement of leg ulcers: a randomized, multicentre, pilot study comparing nitrous oxide-oxygen mixture inhalation and lidocaïne-prilocaïne cream.
Claeys A, Gaudy-Marqueste C, Pauly V, Pelletier F, Truchetet F, Boye T, Aubin F, Schmutz JL, Grob JJ, Richard MA. Claeys A, et al. Among authors: boye t. J Eur Acad Dermatol Venereol. 2011 Feb;25(2):138-44. doi: 10.1111/j.1468-3083.2010.03720.x. Epub 2010 Jun 21. J Eur Acad Dermatol Venereol. 2011. PMID: 20569291 Clinical Trial.
72 results